Fundraising FoxOrserdu
1 known investors
Find your way into Orserdu
Sign up to see every warm intro you have to Orserdu
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orserdu team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ORSERDU (elacestrant) is a prescription oral medication for treating ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer in postmenopausal women and adult men whose disease has progressed after endocrine therapy. The product page is intended for US residents.
Investors · 1
Frequently asked questions
- What does Orserdu do?
- ORSERDU (elacestrant) is a prescription oral medication for treating ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer in postmenopausal women and adult men whose disease has progressed after endocrine therapy. The product page is intended for US residents.
- Who are Orserdu's investors?
- Orserdu's investors include DRI Healthcare.